Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Biodistribution of [18F]Fluoroedaravone in Healthy Adults
NCT07801976Phase 1Not yet recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Dec 2026
- Primary completion
- Nov 2027
01
Overview
Phase 1, open-label, single-arm trial of [18F]fluoroedaravone, sponsored by St. Jude Children's Research Hospital. Primary endpoints: Safety of [18F]fluoroedaravone at 4 days and Biodistribution of [18F]fluoroedaravone at 3 months. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
[18F]fluoroedaravone
Beyond the preview
Go deeper on NCT07801976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07801976.